Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BRD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CASKIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIPF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CA5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2Z - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYSND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060604 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE4D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on